Literature DB >> 14989470

Understanding and circumventing the blood-brain barrier.

D J Begley1.   

Abstract

UNLABELLED: The blood-brain barrier presents a challenging obstacle to effective drug delivery to the central nervous system (CNS). Although biologically intended to protect the brain and spinal cord and provide a very stable fluid environment, the presence of a blood-brain barrier makes treatment of many CNS diseases difficult to achieve, as the required therapies cannot be delivered across the barrier in sufficient quantities or at all. Until relatively recently the blood-brain barrier was viewed largely as a physical barrier to diffusion, and the presence of tight junctions between endothelial cells simply prevented the passive diffusion of solutes from blood into the brain. Recent advances in cell and molecular biology have provided new insights into the function of the blood-brain barrier and it is now appreciated that, in addition to being a physical barrier, it is a complex transport and metabolic barrier and is a highly reactive and dynamic endothelium. Advances in understanding of the cell biology of the blood-brain barrier have opened new avenues and possibilities for improved drug delivery to the CNS. The challenges posed by the blood-brain barrier and the possibilities for overcoming them are reviewed.
CONCLUSION: Increased understanding of the molecular biology of the blood-brain barrier is now opening the way for new strategies to deliver drugs to the CNS.

Mesh:

Substances:

Year:  2003        PMID: 14989470     DOI: 10.1111/j.1651-2227.2003.tb00226.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  12 in total

1.  Enhanced brain distribution of modified aspartoacylase.

Authors:  Nitesh K Poddar; Stephen Zano; Reka Natarajan; Bryan Yamamoto; Ronald E Viola
Journal:  Mol Genet Metab       Date:  2014-07-12       Impact factor: 4.797

2.  Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.

Authors:  Grégoire Dirson; Christine Fernandez; Patrick Hindlet; Françoise Roux; Michèle German-Fattal; François Gimenez; Robert Farinotti
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

3.  Prediction of passive blood-brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors.

Authors:  Santiago Vilar; Mayukh Chakrabarti; Stefano Costanzi
Journal:  J Mol Graph Model       Date:  2010-04-03       Impact factor: 2.518

4.  TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs.

Authors:  Kavitha S Rao; Maram K Reddy; Jayme L Horning; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2008-08-28       Impact factor: 12.479

5.  Assessment of blood-brain barrier permeability using the in situ mouse brain perfusion technique.

Authors:  Rong Zhao; J Cory Kalvass; Gary M Pollack
Journal:  Pharm Res       Date:  2009-04-22       Impact factor: 4.200

6.  Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier.

Authors:  Omid Veiseh; Conroy Sun; Chen Fang; Narayan Bhattarai; Jonathan Gunn; Forrest Kievit; Kim Du; Barbara Pullar; Donghoon Lee; Richard G Ellenbogen; Jim Olson; Miqin Zhang
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

Review 7.  Steps to translate preconditioning from basic research to the clinic.

Authors:  Frances R Bahjat; Raffaella Gesuete; Mary P Stenzel-Poore
Journal:  Transl Stroke Res       Date:  2012-11-02       Impact factor: 6.829

8.  Fexofenadine brain exposure and the influence of blood-brain barrier P-glycoprotein after fexofenadine and terfenadine administration.

Authors:  Rong Zhao; J Cory Kalvass; Souzan B Yanni; Arlene S Bridges; Gary M Pollack
Journal:  Drug Metab Dispos       Date:  2008-12-29       Impact factor: 3.922

9.  Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model.

Authors:  Sylvia Wagner; Anja Zensi; Sascha L Wien; Sabrina E Tschickardt; Wladislaw Maier; Tikva Vogel; Franz Worek; Claus U Pietrzik; Jörg Kreuter; Hagen von Briesen
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

10.  Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.

Authors:  Shijie Jin; Yoshifumi Sonobe; Jun Kawanokuchi; Hiroshi Horiuchi; Yi Cheng; Yue Wang; Tetsuya Mizuno; Hideyuki Takeuchi; Akio Suzumura
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.